期刊文献+

健心颗粒治疗慢性心力衰竭65例临床观察 被引量:23

Clinical Observation on 65 Cases of Chronic Heart Failure Treated with Jianxin Granules
下载PDF
导出
摘要 目的:探讨健心颗粒治疗慢性心力衰竭(CHF)的临床疗效。方法:将128例气虚(阳虚)血瘀、水饮内停证CHF患者随机分为治疗组65例和对照组63例,治疗组在对照组常规治疗基础上加服健心颗粒,连续治疗8周,比较两组临床症状、中医证候疗效及心功能、血浆脑钠肽(BNP)水平改善情况。结果:两组临床症状、中医证候、心功能均有明显改善,且BNP水平均下降;治疗组疗效明显优于对照组。结论:在常规西医治疗基础上加服健心颗粒,可以进一步改善患者的临床症状、心功能及生活质量,安全有效且未出现不良反应。 Objective: To observe clinical therapeutic effect of Jianxin Granules on chronic heart failure (CHF). Methods: 128 cases of Qi deficiency (Yang deficiency),blood stasis and accumulation of excessive fluid in the body were randomly divided into a treatment group of 65 cases and a control group of 63 cases. The treatment group were treated with routine treatment and Jianxin Granules, and the control group with the routine treatment for 8 consecutive weeks. The therapeutic effects on clinical symptoms, TCM syndrome, improvement of cardiac function and plasma brain natriuretic peptide (BNP) level were compared between the two groups, Results:Clinical symptoms,TCM syndrome and cardiac function improved significantly in the two groups. BNP level decreased, and the treatment group was significantly better than the control group (P〈0.05). Conclusion:Routine treatment of western medicine combined with Jianxin Granules can further improve clinical symptoms,cardiac function and life quality of the patient with safety ,effectiveness,and no reverse effect.
出处 《中医杂志》 CSCD 北大核心 2006年第1期28-30,共3页 Journal of Traditional Chinese Medicine
  • 相关文献

参考文献5

二级参考文献16

  • 1Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J, 1991,121(6 Pt 1):1852-1853.
  • 2Vasan RS, Stahl RA, Schwietzer G. The progression from hypertension to congestive heart failure . JAMA, 1996, 275: 1604-1606.
  • 3Guidelines Subcommittee. 1999 World Health Organization-international society of hypertension Guidelines for the Management of Hypertension. J Hypertens,1999,17: 151-183.
  • 4Little WC,Downes TR. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis, 1990, 32:273-290.
  • 5Okin PM, Devereux RB, Jem S, et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Circulation, 2003,12; 108: 684-690.
  • 6Devereux RB, Palmieri V, Sharpe N, et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the pros
  • 7Sheridan DJ. Left ventricular hypertrophy regression: the LIVE trial.Cardiologia,1999,44 Suppl 1(Pt 2):541-543.
  • 8Kannel WB,Castelli WP, McNamara PM,et al. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med, 1972,287:781-787.
  • 9Maeda K,Takayoshi T,Wada A,et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction[].American Heart Journal.1998
  • 10Dickstein K.Natriuretic peptides in detection of heart failure[].The Lancet.1998

共引文献2612

同被引文献194

引证文献23

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部